Johnson & Johnson continues to be a leading employer in the pharma space, providing employees of its Innovative Medicine and MedTech divisions with a competitive benefits and retirement package focused on long-term equity incentives.
That said, the company has made significant changes to its pension plan, which should concern all employees, especially those approaching retirement.
The good news is that J&J tends to have a consistently high stock value. As of 2026, the company has reported 63 consecutive years of dividend increases[i], making it one of the most reliable stocks in the industry. If you are a lifelong J&J employee with stock options, you will do well to hang on to the investment as it is likely to continue trending upwards.
So, what else do you need to know about J&J’s retirement benefits? Let’s take a peek under the hood.
What the Pension Freeze Means for J&J Employees
As of January 1, 2026, J&J’s pension plan is undergoing significant changes. Essentially, they are hard-freezing the Final Average Pay (FAP) for eligible employees. As of the first of this year, any employee hired on or before December 31, 2014, will not accrue based on additional salary increases or years of service after January 1.
For those who fall into the above category, what this means is that earnings up to January 1 are locked in, but you will not accrue higher benefits going forward.
Employees with a frozen plan may draw a monthly payout starting at age 55. There is no lump-sum payment offered with this plan.
If you are affected by this new rule, we encourage you to reach out to Randall so we can review your plan documentation and make decisions about your retirement strategy.
Notable considerations include:
- Available to employees hired before December 31, 2014.
- Vesting is achieved at age 55 or after five years of service.
- If you retire at or after age 55 and have at least 10 years of service, your benefit will be reduced by 4% for each year before you turn 62.
FAP vs. RVP: What You Need to Know
J&J also has a Retirement Value Pension (RVP), which applies to those hired after December 31, 2014, and has similar vesting rules and early retirement reductions.
The most significant difference is that you may choose a lump-sum payout or an annuity, but there are also differences in how the pension is calculated. The FAP, for example, is based on years of service and final average pay.
The RVP, on the other hand, is based on contributions and investment performance. Luckily, the stocks tend to hold their value, so that’s good news.
Whether you have the RVP or the FAP, it’s critical to understand the features of the plan, especially where survivor benefits are concerned. Though choosing a survivor benefit may reduce your monthly payout, it can provide your family with priceless resources after you’re gone. While everybody’s situation is different, you must consider what’s important to you. If you have children or grandchildren, or simply want to ensure your spouse is taken care of, the survivor benefit can help.
A qualified financial professional can work with you to review your documents and help you make the right decisions for your family’s future.
Ultimately, the longer you work for the company, the more your benefits will grow, especially if you are a long-time employee with FAP.
Under both plans, early retirement will impact your pension, so it’s something to think about when planning.
Coordinating Your Pension with Other Retirement Savings
Your J&J pension is just one piece of the puzzle. When you consider other investments offered by the company, like IRAs and 401(k)s, we can align to create a financially viable plan that helps ensure your confidence in retirement.
For employees with an RVP and fewer years of service, these decisions will be especially critical as the weight of your pension will rely heavily on these investments.
A Few Words About Equity Compensation
For J&J employees and executives, a significant portion of compensation comes from equity vehicles, such as restricted stock units (RSUs), performance share units (PSUs), stock purchase programs, and incentives.
And while these benefits can help to accumulate wealth, they can also introduce unwelcome tax surprises.
For example, multiple vesting events can increase income into higher tax brackets, as they are taxed as ordinary income at vesting. Additionally, you may have unrealized gains tied up in company stock, which represents a risk and should be managed accordingly.
Strategies include diversification, charitable giving using appreciated shares, timing your capital gains, or tax-loss harvesting into other accounts.
Working with a qualified pharma financial advisor, together we can choose the approach that’s right for you.
Don’t Overlook Healthcare and HSAs
Ongoing healthcare and long-term care needs are unpredictable expenses and often overlooked.
Reviewing your benefits package in advance of retirement will help you understand your retiree medical coverage, Medicare options, premium costs, and how your HSA factors in.
HSAs, in particular, are one of the most tax-advantaged tools you have available to you. All contributions are pre-tax, growth is tax-deferred, and anything you withdraw for a qualified expense is tax-free.
If you can afford to let your HSA grow, it can provide you with a substantial asset in retirement where healthcare costs are concerned.
The Bottom Line
If you’re a J&J employee nearing retirement, you should take some comfort in knowing that your investments and stock options are among the most stable in the industry. However, since the company’s pension plan has undergone recent and significant changes, planning is critical. Benefits alone will not ensure financial independence.
If you are within 10–15 years of retirement, now is the ideal time to review your pension status and stock concentration, and to ensure equity compensation is managed strategically.
Do you ever worry about your J&J stock? The good news is you can receive a complimentary Morningstar report on your company stock when you schedule a brief intro call with me.
It’s a simple perk: you get a customized snapshot of what investment researchers are saying (ratings, risks, and key fundamentals) so you can be more informed about your shares. Let's see if working with a Financial Advisor with a pharma focus is a good fit for your needs.
If not, no hard feelings; I’ll point you in the right direction. Book your spot and claim your report here:
Information was obtained from sources believed to be reliable as of the current date, but no representation is being made as to its accuracy and completeness. Benefits may be subject to change at Johnson & Johnson's discretion.
Randal Defillippis and LPL Financial are not affiliated with or endorsed by Johnson & Johnson.
This material was created for educational and informational purposes only and is not intended as ERISA, tax, legal or investment advice. If you are seeking investment advice specific to your needs, such advice services must be obtained on your own separate from this educational material.